Journal of Infection and Chemotherapy

Aims & Scope

The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs.

Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.5
2024	1.90

Journal Rank

Year	Value
2024	9948

Journal Citation Indicator

Year	Value
2024	1462

SJR (SCImago Journal Rank)

Year	Value
2024	0.584

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	76

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases

  Citation: 825

  Authors: Yasuyoshi, Tsugunori

• Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases

  Citation: 292

  Authors: Shigenobu, Mohammad, Jumpei, Shingo, Takako, Masayuki, Shosuke, Masahiko, Toshikazu, Mikiya, Hiroshi

• Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome

  Citation: 255

  Authors: Tatsuyori, Gaku, Naoya, Masahiro, Shigeatsu, Yoshikazu

• Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis

  Citation: 237

  Authors: Yasunori, Nobuhiro, Yasushi, Masahiro, Satoko, Gaku, Michiko, Shigeatsu, Kamon, Shoji

• Loop-mediated isothermal amplification (LAMP): recent progress in research and development

  Citation: 226

  Authors: Yasuyoshi, Hidetoshi, Tsugunori

• Plasmid-mediated quinolone resistance: an update

  Citation: 226

  Authors: José Manuel, Carmen, Álvaro, María Eliecer, Luis, Luis, Álvaro

• Challenges and new discoveries in the treatment of leishmaniasis

  Citation: 220

  Authors: Sarman, Ramu

• Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study

  Citation: 216

  Authors: Shigeatsu, Yasushi, Gaku, Tatsuyori, Hiroyasu, Akira, Takeshi, Yuhei, Masanao, Hironobu, Yasuo, Kimiaki, Tsuyoshi, Yoshikazu

• The ABCD’s of β-lactamase nomenclature

  Citation: 208

  Authors: Karen

• An overview of infectious complications after allogeneic hematopoietic stem cell transplantation

  Citation: 204

  Authors: Ugur, Selami Kocak, Pinar Ataca, Erden, Taner

---